- Previous Close
3.1850 - Open
3.1600 - Bid 3.1700 x --
- Ask 3.0800 x --
- Day's Range
3.1500 - 3.1800 - 52 Week Range
3.0200 - 3.7750 - Volume
21,947 - Avg. Volume
23,566 - Market Cap (intraday)
273.048M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
www.bioton.pl355
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Biotechnology
Industry
Recent News: BIO.WA
View MoreCompare To: BIO.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIO.WA
View MoreValuation Measures
Market Cap
273.48M
Enterprise Value
324.90M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.54
Price/Book (mrq)
0.46
Enterprise Value/Revenue
1.83
Enterprise Value/EBITDA
8.07
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.27%
Return on Assets (ttm)
-1.10%
Return on Equity (ttm)
-0.97%
Revenue (ttm)
177.6M
Net Income Avi to Common (ttm)
-5.8M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
623k
Total Debt/Equity (mrq)
8.74
Levered Free Cash Flow (ttm)
7.52M